This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the Invesco SP SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
4 Sector ETFs Grab Attention on Solid Job Creation
by Sanghamitra Saha
The U.S. economy added 1.371 million jobs in August 2020, decreasing from the downwardly revised 1.734 million in the previous month and slightly below market forecasts of 1.4 million.
Should You Invest in the Invesco SP SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
ETFs in Focus on Momenta Buyout Deal With JNJ
by Sweta Killa
A number of ETFs could be the best ways for investors to tap the opportunity arising from the Momenta buyout deal.
S&P 500 Near Record Close: 3 Winning Sectors & ETFs
by Sanghamitra Saha
S&P 500 got charged up on Aug 12 on vaccine and further stimulus hopes as well as better-than-feared second-quarter earnings.
4 Sector ETFs & Stocks to Buy on Forecast-Beating Jobs Data
by Sanghamitra Saha
The U.S. economy added 1.76 million jobs in July 2020, down from a record 4.8 million in the previous month. However, the reading beat market expectations of a 1.6 million increase.
Should You Invest in the Invesco SP SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
What Lies Ahead for Healthcare ETFs in Q2 Earnings?
by Sweta Killa
The healthcare sector is expected to witness substantial earnings decline of 6.9% in the second quarter, representing the second strongest sector this earnings season.
UnitedHealth Beats: Healthcare ETFs in Focus
by Sweta Killa
UnitedHealth Group reported stronger-than-expected second-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues.
Should You Invest in the Invesco SP SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Jobs Market Strengthening Fast: 4 Sector ETFs & Stocks to Buy
by Sanghamitra Saha
The U.S. economy unexpectedly added 4.8 million jobs in June, breezing past economists??? expectations of job gains of 2.9 million.
4 ETF Investing Styles for Q3
by Sanghamitra Saha
At the start of Q3, the operating and investing backdrop looks mixed. The second wave of virus contagion has already hit the market and threatening the speed of recovery while several economic data points are coming in upbeat thanks to the reopening.
4 Sector ETFs for July
by Sanghamitra Saha
At the onset of 2H, the operating and investing backdrop looks mixed as the second wave of virus contagion has already hit while several economic datapoints are coming in upbeat thanks to the unlocking of economies.
4 Sector ETFs & Stocks to Buy on Record Jobs Gain in May
by Sanghamitra Saha
The U.S. jobs report for the month of May reflected the largest one-month job gains.
Play Sector ETFs With Strong Beat Ratios
by Sanghamitra Saha
These sectors came up with stellar earnings beat in the recent cycle. Investors can play the related ETFs.
Should You Invest in the Invesco SP SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
Worst U.S. Job Market: Most & Least Hurt Sector ETFs
by Sanghamitra Saha
The U.S. job market has seen the worst month history hurt by the coronavirus-led lockdowns.
Don't Sell in May, Rather Buy These ETFs
by Sanghamitra Saha
The proverb "sell in May and go away" proved itself wrong in the past few years with the May-October period turning pretty profitable.
ETF Asset Report of Coronavirus-Inflicted April
by Sanghamitra Saha
These ETF areas have gained or lost assets in the month of April.
Healthcare ETFs to Gain on Progress in Coronavirus Vaccine
by Sweta Jaiswal, FRM
The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.
Healthcare ETFs Looks Strong Ahead of Q1 Earnings
by Sweta Killa
The healthcare sector has been on a tear driven by potential vaccines and treatments for COVID-19.
Healthcare ETFs to Gain on Progress in COVID-19 Antibody Tests
by Sweta Jaiswal, FRM
Along with molecular testing, antibody testing is gaining immense prominence as economies are struggling to reopen.
Healthcare ETFs in Focus Post UnitedHealth's Q1 Earnings
by Sweta Killa
UnitedHealth reported mixed first-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on earnings but lagged the same for revenues.
JNJ Beats, Cuts View on Coronavirus: Healthcare ETFs in Focus
by Sweta Killa
Investors should closely watch the movement of the stock and keep a close eye on ETFs having double-digit allocation to this diversified drug maker post its earnings release.